20240322-太平洋-百亚股份-003006.SZ-大健康兼外围市场驱动收入增长_结构持续优化扩增盈利_5页_657kb

Analysis Summary

Company: Baiya Co., Ltd. (Stock Code: 003006)
Sector: Health & Personal Care
Research Report: Pacific Securities
Date: March 22, 2024
Recommendation: Buy/Maintain

Key Highlights:

1. Financial Performance (2023):
   • Revenue Growth: +3300% for 2023, to RMB 21.44 billion.
   • Net Profit Growth: +2721%, reaching RMB 23.8 billion.
   • Q4 2023 saw revenue +3839%, but net profit declined by 8.65%.
2. Drivers of Growth:
   • Health & Personal Care Products: Free Points category grew +4115%, accounting for 88.15% of revenue.
     • Health-focused products (e.g., organic cotton, sensitive skin) drove faster growth.
   • Channel Expansion:
     • E-commerce revenue surged +10152% (RMB 74.8 billion, ~30% of total revenue).
     • Core markets expanded +1345% (RMB 10.37 billion in May 2023).
     • Peripheral markets showed +2123% growth (RMB 2.38 billion).
3. Profitability Improvements:
   • Gross Margin increased to 50.32%, Free Points products recorded 54.84% GM.
   • Brand investments (RMB 66.9 billion in SG&A) supported product launches and marketing.
   • D研发投入 increased, with 28 new patents filed in 2023.

Investment Outlook:

• Expected revenue for 2024-2026: RMB 28B, 34B, 41B.
• Projected net profit: RMB 30.9B, 37.8B, 46.7B.
• PE ratios: 23x, 18x, 15x for 2024-2026.
• Recommendation: Maintain "Buy" rating, based on continued expansion and profit improvement.

Risks:

• Delay in new factory construction, high competition, and raw material costs.

```md
[Added in Chinese as per request]  

### 公司概况
百亚公司为西南老牌卫生巾龙头，业绩优异，近年通过大健康产品创新和全国化扩展实现高速增长。

### 核心亮点 
1. 业绩表现亮眼  
   公司2023年实现营收和净利润大幅增长（3300%/2721%），中高端产品大健康矩阵驱动增长。
2. 渠道拓展加速  
   线上渠道成为新增长极，电商收入增长超10倍；线下外拓市场收入增幅达2123%。
3. 盈利结构优化  
   毛利率从45.11%增至50.32%，品牌投资和研发投入同步提升，未来增长具备支撑。

### 投资建议（根据MacChian推荐）
维持“买入”评级，未来三年营业收入与净利润预计年复合增长率较高，估值进一步压缩显示市场看好长期发展能力。

### 风险提示
需关注新品上市进度、行业竞争加剧落地及原材料成本变动因子。